Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.

Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.
复制标题

DOI:
10.1038/s41467-022-29442-x
复制
发表时间:
2022-04-08
影响因子:
16.6
通讯作者:
Peeper DS
Peeper DS
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Apriamashvili G;Vredevoogd DW;Krijgsman O;Bleijerveld OB;Ligtenberg MA;de Bruijn B;Boshuizen J;Traets JJH;D'Empaire Altimari D;van Vliet A;Lin CP;Visser NL;Londino JD;Sanchez-Hodge R;Oswalt LE;Altinok S;Schisler JC;Altelaar M;Peeper DS

文献摘要

参考文献

被引文献

相似文献

The cytokine IFNγ differentially impacts on tumors upon immune checkpoint blockade (ICB). Despite our understanding of downstream signaling events, less is known about regulation of its receptor (IFNγ-R1). With an unbiased genome-wide CRISPR/Cas9 screen for critical regulators of IFNγ-R1 cell surface abundance, we identify STUB1 as an E3 ubiquitin ligase for IFNγ-R1 in complex with its signal-relaying kinase JAK1. STUB1 mediates ubiquitination-dependent proteasomal degradation of IFNγ-R1/JAK1 complex through IFNγ-R1K285 and JAK1K249. Conversely, STUB1 inactivation amplifies IFNγ signaling, sensitizing tumor cells to cytotoxic T cells in vitro. This is corroborated by an anticorrelation between STUB1 expression and IFNγ response in ICB-treated patients. Consistent with the context-dependent effects of IFNγ in vivo, anti-PD-1 response is increased in heterogenous tumors comprising both wildtype and STUB1-deficient cells, but not full STUB1 knockout tumors. These results uncover STUB1 as a critical regulator of IFNγ-R1, and highlight the context-dependency of STUB1-regulated IFNγ signaling for ICB outcome. The IFNγ response pathway is associated with response to immunotherapy in cancer. Here the authors show that high levels of the IFNγ-receptor (IFNγ-R1) affect the outcome of immunotherapy in a context-dependent fashion and identify the E3 ubiquitin ligase STUB1 as a negative regulator of IFNγ-R1/JAK1 expression in cancer cells.
DOI: 10.1093/bioinformatics/btu638
发表时间: 2015-01-15
期刊: Bioinformatics (Oxford, England)
影响因子: --
作者:
Anders S;Pyl PT;Huber W
通讯作者: Huber W
DOI: 10.1016/j.str.2016.03.023
发表时间: 2016-06-07
期刊: Structure (London, England : 1993)
影响因子: --
作者:
Ferrao R;Wallweber HJ;Ho H;Tam C;Franke Y;Quinn J;Lupardus PJ
通讯作者: Lupardus PJ
DOI: 10.1016/j.cell.2016.11.022
发表时间: 2016-12-01
期刊: Cell
影响因子: 64.5
作者:
Benci JL;Xu B;Qiu Y;Wu TJ;Dada H;Twyman-Saint Victor C;Cucolo L;Lee DSM;Pauken KE;Huang AC;Gangadhar TC;Amaravadi RK;Schuchter LM;Feldman MD;Ishwaran H;Vonderheide RH;Maity A;Wherry EJ;Minn AJ
通讯作者: Minn AJ
DOI: 10.1016/1074-7613(94)90087-6
发表时间: 1994-09-01
期刊: IMMUNITY
影响因子: 32.4
作者:
DIGHE, AS;RICHARDS, E;SCHREIBER, RD
通讯作者: SCHREIBER, RD
DOI: 10.1038/35050618
发表时间: 2001-01-01
影响因子: 21.3
作者:
Connell, P;Ballinger, CA;Patterson, C
通讯作者: Patterson, C